Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial).
Claudia MarchettiRiccardo TudiscoVanda SalutariAntonella PietragallaGiovanni ScambiaAnna FagottiPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
NCT04261465.